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Biofilms are typically studied in bacterial media that allow the study of important
properties such as bacterial growth. However, the results obtained in such media
cannot take into account the bacterial localization/clustering caused by bacteria–protein
interactions in vivo and the accompanying alterations in phenotype, virulence factor
production, and ultimately antibiotic tolerance. We and others have reported that
methicillin-resistant or methicillin-susceptible Staphylococcus aureus (MRSA or MSSA,
respectively) and other pathogens assemble a proteinaceous matrix in synovial fluid.
This proteinaceous bacterial aggregate is coated by a polysaccharide matrix as is
characteristic of biofilms. In this study, we identify proteins important for this aggregation
and determine the concentration ranges of these proteins that can reproduce bacterial
aggregation. We then test this protein combination for its ability to cause marked
aggregation, antibacterial tolerance, preservation of morphology, and expression of the
phenol-soluble modulin (PSM) virulence factors. In the process, we create a viscous
fluid that models bacterial behavior in synovial fluid. We suggest that our findings and,
by extension, use of this fluid can help to better model bacterial behavior of new
antimicrobial therapies, as well as serve as a starting point to study host protein–bacteria
interactions characteristic of physiological fluids.
Keywords: Staphylococcus aureus, biofilm, synovial fluid, antibiotic tolerance, virulence factors

INTRODUCTION
Despite aggressive treatment and the use of local supratherapeutic concentration of antimicrobials,
joint infections can persist (Kunutsor et al., 2018), even in the absence of implants. The presence
of synovial fluid in the joint fosters the formation of dense, proteinaceous, free-floating biofilm
aggregates (Dastgheyb et al., 2015a,b; Crosby et al., 2016; Gilbertie et al., 2019; Pestrak et al.,
2020), the removal of which is required for successful treatment of infection. The bacteria–protein
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study bacterial behavior in fluids that more closely approximate
in vivo biofilm characteristics.

interactions in these aggregates induce alterations in phenotype,
virulence factor production, and ultimately marked antibiotic
tolerance (Dastgheyb et al., 2015a,b,c), akin to what has been
described for adherent biofilms.
Under conditions that mimic the physiological environment,
bacterial aggregation also occurs in vitro, where microscopic
clusters are seen in serum and microscopic and macroscopic
clusters are visible in synovial fluid (Dastgheyb et al., 2015a;
Crosby et al., 2016). We and others have reported that in
synovial fluid, methicillin-resistant or methicillin-susceptible
Staphylococcus aureus (MRSA or MSSA, respectively) and other
pathogens assemble a proteinaceous matrix that is coated by
polysaccharides as is characteristic of biofilms (Dastgheyb et al.,
2015b; Perez and Patel, 2015; Gilbertie et al., 2019). Aggregation
depends on microbial surface components recognizing adhesive
matrix molecules (MSCRAMMs) and the master biofilm
regulator accessory gene regulator (Agr) (Dastgheyb et al.,
2015b). Agr-regulated virulence factors, specifically phenolsoluble modulins (PSMs), are downregulated in synovial fluid.
This downregulation appears to have consequences on bacterial
aggregation, as we found that overexpression of any type of
PSM (PSMα, PSMβ, and delta toxin) abrogated synovial fluidinduced aggregation. These findings support the notion that
suppression of Agr and the concomitant strong suppression of
PSM production are critical for MRSA aggregation (Dastgheyb
et al., 2015c). Thus, these reports challenge whether drugs
that act through inhibition of agr-mediated gene expression,
such as production of proteins important for quorum sensing,
will result in a benefit to the host during periprosthetic joint
infection (PJI) (Piewngam et al., 2020). In light of these
findings, we reasoned that it would be important to begin
mapping the components of these aggregates to allow better
modeling both for implant development as well as for combatting
joint infection.
Synovial fluid is central to aggregation and is a proteinrich viscous fluid composed of proteins filtered from blood
and secreted proteins/proteoglycans from cells (predominantly
synovium and cartilage). In our studies, we have recognized
that synovial fluid shows donor variability, perhaps where
composition reflects disease state (Mateos et al., 2012; Noh
et al., 2014). To circumvent this limitation, we have established
equine or porcine synovial fluid as a readily available source
of “normal” synovial fluid that reproduces the reported
aggregatory behavior and phenotype over multiple bacterial
species (Gilbertie et al., 2019).
In this study, we set out to determine which proteins in
synovial fluid were predominantly responsible for staphylococcal
aggregation. To do that, the abundant proteins sequestered
in synovial fluid bacterial aggregates were identified and their
roles were investigated. Based on these determinations, we next
evaluated if the presence of these proteins/proteoglycans could
reproduce the phenotype of synovial fluid bacterial aggregates,
where our criteria were (1) morphology, (2) composition, (3)
antimicrobial tolerance, and (4) virulence factor production. As
a consequence of these studies, we have developed a “pseudo”
synovial fluid (pSynF) that embodies many of the characteristics
of native synovial fluid and serves as a readily accessible means to
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MATERIALS AND METHODS
Ethics Statement
Human synovial fluid and other surgical waste were obtained
from therapeutically necessary joint aspirations or operations.
This material, designated as “waste” (no identifiers), was retrieved
and designated as “not human research” by the Thomas Jefferson
University Office of Human Research Protections in keeping with
the revised Federal Policy for the Protection of Human Subjects
(revised Common Rule, 2018).

Bacterial Strains and Growth
MSSA ATCC 25923TM and MRSA LAC USA300 [parent strain,
giving rise to LAC psmα-lux, LAC psmβ-lux, or LAC P3-lux
strains (Dastgheyb et al., 2015c)] were grown from a single colony
in Trypticase Soy Broth (TSB; Becton-Dickinson, Sparks, MD)
overnight (ON), 37◦ C, 180 rpm. ON cultures were diluted by
comparison to a 0.5 McFarland standard [∼108 colony-forming
unit (CFU)/ml for S. aureus].
R

Clinical Samples
Except for the PJI samples, synovial fluid used in this manuscript
was collected as discarded material from routine office aspirations
from patients with sterile fluid excess. Eight of those were
used without pooling for determination of MSSA aggregate
characteristics by sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS-PAGE) and Western blotting. Otherwise,
2–5 samples were pooled to allow volumes large enough to
perform the various activity/expression assays throughout the
rest of the manuscript. The infected samples were collected as
waste from revision surgeries for treatment of confirmed PJI
and represented implant-adherent biofilm and non-attached
biofilm. A small sample was scraped from the implant (biofilm
sample), and another sample was retrieved from the discarded
fluid material that was flushed from the bone cavity (floating
aggregate). Material was placed into labeled 50-ml conical tubes,
fixed by incubation in formalin, and, after rinsing, prepared for
imaging by scanning electron microscopy (SEM). The identity
of the bacterial strain causing PJI was not supplied with
the fixed samples.

Biofilm Formation
To form biofilms in vitro, MSSA (105 CFU/ml) were incubated in
TSB or human synovial fluid for 24 h, 37◦ C, without agitation
using 1 cm × 2 mm Ti6Al4V coupons (kind gift of Zimmer).
Surfaces were gently rinsed 3 × with phosphate buffered
saline (PBS) and fixed with 4% paraformaldehyde, ON, 4◦ C.
Samples were then prepared for SEM. Clinical examples were
composed of samples of infected reamings from a PJI patient as
well as several scrapings from the implant removed during the
patient’s treatment. From this formalin-fixed material, at least
three samples were removed and rinsed and solid material was
affixed to a slide followed by dehydration, sputter coating, and
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SEM analysis. Micrographs were compared for fibrous material,
presence of blood cells, and apparent biofilm-like structures
that could be attributed to bacteria. Images representative of
these are shown.

Scanning Electron Microscopy
Bacterial aggregates were fixed with 4% paraformaldehyde,
room temperature (RT), 10 min, and dehydrated by sequential
incubation (RT, 10 min) with 10, 30, 50, 70, 90, and 100% ethanol
in PBS. Samples were dried ON, sputter-coated with gold, and
imaged using a Hitachi TM-1000 SEM.

Determination of Interplay of Synovial
Fluid Components on
Methicillin-Susceptible Staphylococcus
aureus Aggregation and Formation of
Pseudo Synovial Fluid

Fractionation by Sodium Dodecyl
Sulfate–Polyacrylamide Gel
Electrophoresis: Pseudo Synovial Fluid
or Human Synovial Fluid

Hyaluronic acid (HA; Streptococcus equi, 91% high molecular
weight (MW); Alfar Aesar, Tewksbury, MA) was dissolved (ON,
4◦ C) to 4.05 mg/ml in sterile TSB. Fibrinogen (Fg; Alfa Aesar,
Tewksbury, MA, United States) was dissolved to 60, 90, and
120 mg/ml in PBS, pH 8.5, by incubation at 37◦ C, 3 min, followed
by vortexing. Albumin (Alb; Fisher Scientific, Pittsburgh, PA,
United States) was dissolved to 60, 120, and 180 mg/ml in PBS,
pH 8.5. All stocks were sterile filtered (0.2 µm filter) and stored
at 4◦ C for up to 2 days.
A concentration matrix of Fg, Alb, and HA was created in
96-well plates. TSB (140 µl) containing 0, 1.5, or 3.0 mg/ml
HA was added to each well; 20 µl of Fg stocks were added
to give 0, 6, 9, or 12 mg/ml and 20 µl of Alb stocks to yield
0, 6, 12, and 18 mg/ml. Lastly, 20 µl of 108 CFU/ml MSSA
in sterile PBS were added into each well to yield 107 CFU/ml.
Plates were incubated, 37◦ C, 180 rpm, 90 min to allow bacterial
aggregation. Samples were serially diluted, followed by plating on
Petrifilms; reduced bacterial counts were considered aggregation
events (1 CFU would equal one aggregate in that instance). Each
individual condition was determined in triplicate, with three
independent experiments to yield an n = 8 or 9 for each condition.
The combination of 3.0 mg/ml HA, 9 mg/ml Fg, and 10 mg/ml
Alb in TSB was referred to as pSynF.

Synovial fluid samples were obtained from individual donors
(n = 8), each separately labeled with a different number. Before
fractionation, samples were diluted to 3% with sterile PBS.
Aggregates formed as above were pelleted at 13,000 × g, 3 min,
washed, and resuspended in 1 ml PBS by repeated vortexing and
pipetting. Laemmli sample buffer with β-mercaptoethanol was
added (1:1), samples heated at 70◦ C for 10 min, placed on ice,
and fractionated (105 V, ∼70 min) on an SDS-polyacrylamide
gel (7.5%), using the discontinuous buffer system of Laemmli
(1970). MW standards (10–250 kDa; Precision Plus ProteinTM
Dual Color Standards, Bio-Rad, Hercules, CA, United States)
were run on the same gel, as were serum, Fg (Alfa Aesar), and
Alb (Thermo Fisher Scientific).

Western Blotting
Following fractionation, protein bands were transferred (1.3
A, 25V, 7 min) to nitrocellulose membranes (Bio-Rad) using
the Trans Blot Turbo Transfer System (BioRad) with Turbo
transfer buffer. Membranes were blocked by incubation in 10%
nonfat milk (BioRad) in Tris-Buffered Saline (1×) containing
0.5% Tween-20 (10% TTBS), 60 min, followed by incubation
with mouse anti-Fg (1:1,000; Sigma-Aldrich F9902) or rabbit
anti-Alb (1:1,000; Sigma-Aldrich, SAB4200656) antibody, in 5%
TTBS, 4◦ C, ON, with shaking. The blot was then washed
3× with 10% TTBS, incubated in horseradish peroxidase (HRP)linked goat anti-mouse (Bio-Rad; 1:10,000) or HRP-linked goat
anti-rabbit antibody (Abcam, Cambridge, MA; 1:20,000), RT,
2 h, washed 3×, followed by visualization using PierceTM
ECL Western Blotting Substrate (Thermo Fisher Scientific,
Rockford, IL, United States). In all gels and blots, results
were repeated using additional aggregates formed in the same
or different synovial fluid sample with similar appearances.
Densitometry was performed using three different exposures
of each blot. The amount of Fg in samples was calculated by
comparison to the band area in 100 µg Fg control for each
of the exposures.

Bacterial Aggregate Formation and
Antibiotic Treatment
Pooled synovial fluid was formed by combining 2–5 samples from
individual donors to better allow reproducibility. Here, 0.2, 1.0,
or 3.0 ml of human synovial fluid (≥90% final volume), pSynF,
human serum (Sigma, not heat inactivated) or TSB in 6-, 24-, or
96-well tissue culture plates (Med Supply Partners, Atlanta, GA),
respectively, were inoculated with 107 or 108 CFU/ml MSSA or
MRSA and incubated for a minimum of 90 min, 37◦ C, 125 rpm.
Either during or after aggregation, amikacin (AMK) was added
(0–200 µg/ml) and incubated for 6 h. At 6 h, bacteria were
pelleted and washed [when aggregate dispersal was used, the
resulting pellet was treated with 1 ml of 0.25% trypsin (Corning),
37◦ C, 180 rpm, 20 min, and pelleted again]. All pellets were then
washed with PBS, resuspended by pipetting/vortexing and, after
serial dilution, plated on 3MTM PetrifilmTM aerobic count plates
(3M Corporation, St. Paul, MN), followed by direct counting
(countable range, 30–300 CFU/spot). This dispersal method was
validated by the (1) disappearance of visible aggregates and (2)
equivalence of CFU (after Trypsin) with CFU recovered from
TSB using an equal bacterial inoculum.

Frontiers in Microbiology | www.frontiersin.org

Synovial Fluid Fractionation
Pooled synovial fluid was formed by combining 2–5 samples
from individual donors to better allow reproducibility. Protein
was precipitated from pooled human synovial fluid (Qiu et al.,
2003) by addition of 200 proof (100%) absolute ethanol, 4◦ C,
to a final concentration of 10%, followed by ON incubation,
4◦ C. Protein precipitates were collected, 1,100 × g, 5 min, 4◦ C,
where the pellet represented a Fg-enriched fraction (ppt) and the
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supernatant, a Fg-depleted synovial fluid (depSynF). SDS-PAGE
and Western blotting were used to determine the extent of Fg
depletion. Upon Fg re-addition, the concentrations added were
6, 9, and 12 mg/ml.

RESULTS
Staphylococcus aureus Aggregates in
Human Synovial Fluid Are Rich in
Fibrinogen and Albumin

Viscosity Determination

We started our investigation by asking if the aggregates and
biofilms formed in vitro in human synovial fluid approximated
the aggregates formed in an infected joint. By SEM (Figure 1A;
all in vitro images are representative of at least three samples),
the adherent biofilm retrieved from an implant in a case of
clinically confirmed PJI was rich in proteins and even showed
the presence of red blood cells. In vitro, MSSA biofilm formed
in human synovial fluid on smooth titanium alloy (Ti6Al4V)
was relatively sparse and much simpler than the PJI biofilm. The
major similarity was that bacteria/biofilm showed clear fibers
within and between biofilm clusters. In TSB, MSSA was largely
clustered and covered by biofilm; any underlying fibrils were
not as apparent as on Ti6Al4V. The non-adherent aggregate
retrieved from the PJI fluid (clinical aggregate) showed large
globular bacterial aggregates immobilized on a fibrous matrix and
encased in biofilm. Like the PJI aggregate, large, globular, floating
MSSA aggregates were formed in vitro in human synovial fluid
from a single donor; individual bacteria were also visible and
many of these were obscured by biofilm coating (Figure 1A).
Because MSSA does not aggregate in TSB, no clear picture was
able to be taken.
Based on our previous work (Dastgheyb et al., 2015b,c;
Gilbertie et al., 2019), the abundant serum protein Fg was likely
an important component of aggregates. We asked if we could
identify the most abundant proteins in the aggregate, if they
included Fg among other proteins, and if protein abundance
was similar to the parent synovial fluid. Based on electrophoretic
fractionation, the size distribution and relative amounts of
human synovial fluid proteins from individual donors (SynF1,
2, 3) largely mirrored those found in human serum (Figure 1B;
aggregates from the samples were fractionated on at least three
gels). Proteins in the 50–75 kDa were most abundant in all
samples, whereas high-MW components, which would include
fibronectin (Fn), were not sufficiently abundant to be apparent
with Coomassie staining of these gels. Based on staining intensity,
bacterial aggregates formed in synovial fluid appeared to be
composed predominantly of the same abundant proteins found
in the parent synovial fluid.
Fg and Alb are both abundant in osteoarthritic synovial
fluid (Fitowska et al., 2012; Mateos et al., 2012; Ritter et al.,
2013). Thus, we investigated if the intense bands noted in
the bacterial aggregates in Figure 1B could be associated
with Fg and Alb. Both synovial fluid and their corresponding
bacterial aggregates showed clear presence of Fg and Alb by
Western blotting (Figure 1C). In the left-hand blot, the Alb
content of three different synovial fluid samples (SynF 6, 7,
8) and their corresponding macroscopic aggregates are shown.
In the right-hand blot, the Fg content of three additional
human synovial fluid samples (SynF 3, 4, 5), along with
the Fg content of aggregates formed in those synovial fluids,
are shown. Both blots demonstrated that Alb and Fg were

The viscosity of pooled synovial fluid and pSynF was measured
by a homemade viscometer (Tang, 2016) using the following
equation:
d2 (ρb − ρl ) g sin θ
η =
T
18L
T = time (s) for a 2-mm diameter (d) ball bearing to traverse
0.1 m (L) of liquid in a 2-ml serological pipette. η = viscosity,
ρb = 5156.6 kg/m3 = ball density; ρl = 1,000, 1,002, or
1,034 kg/m3 , which are the density of water, synovial fluid, or
pSynF, respectively; g = 9.8 m/s2 = gravitational acceleration;
θ = π/3 radians = angle of the pipette with respect to the
horizontal. Finally, all values were adjusted by multiplied by the
ratio of the established viscosity of water over the viscosity of
water in this experiment (Tang, 2016).

Wheat Germ Agglutinin Staining
Bacterial aggregates were rinsed three times with sterile PBS,
fixed with 4% paraformaldehyde, 37◦ C, 15 min, rinsed three
times with sterile PBS, and stained with 5 µg/ml AlexaFluor 488
conjugated wheat germ agglutinin (WGA; Invitrogen), 10 min,
RT. Stained aggregates were rinsed three times with sterile
PBS and imaged at 488 nm using a confocal laser scanning
microscope (Zeiss LSM800).
R

Phenol-Soluble Modulin Luminescence
Assay
LAC psmα-lux, LAC psmβ-lux, or LAC P3-lux strains of USA300
MRSA were inoculated (Cf ∼106 CFU/ml) in TSB, human serum,
pooled synovial fluid, or pSynF to a final volume of 5.0 ml,
followed by incubation for up to 24 h (225 rpm, 37◦ C). Every
2 h, while maintaining temperature, samples were vortexed,
2 × 100 µl were removed and placed in clear bottom white plates,
and luminescence was measured using a VeritasTM microplate
luminometer (Turner Biosystems, Sunnyvale, CA, United States).
In parallel, absorbance (λ = 600 nm) was measured on the
same samples to determine bacterial growth (Tecan Infinite
M1000 plate reader). Luminescent values were normalized to
the absorbance at 600 nm and expressed as relative luminescent
units (RLUs). Each point was determined in duplicate in a
minimum of three independent experiments.

Statistics
Statistical significance was determined using the Student’s t-test
or the Mann–Whitney U-test for simple comparisons. More
complex comparisons were analyzed by one-way or two-way
ANOVA with a Tukey’s post hoc test. Alpha values were set
to 0.05, and the statistical analyses were performed using SPSS
IBM SPSS Statistics Version 26 or Prism GraphPad 9.0.1.
R

R
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FIGURE 1 | Synovial fluid aggregate morphology and composition. (A) (Top) Using SEM, biofilm morphology in samples retrieved from an infected knee replacement
[periprosthetic joint infection (PJI)] or formed on titanium using methicillin-susceptible Staphylococcus aureus (MSSA) in human synovial fluid (SynF) or Trypticase Soy
Broth (TSB). (Bottom) Floating aggregates retrieved from an infected knee replacement or floating aggregates formed with MSSA in human synovial fluid.
(B) Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) gel stained with Coomassie Blue. The gel shows the composition of human synovial
fluid and of synovial fluid MSSA aggregates from three separate samples of synovial fluid, as compared to fibronectin (Fn), fibrinogen (Fg), albumin (Alb), and serum
controls. (C) Western blot analysis of MSSA aggregates from synovial fluid for Alb (left) and for Fg (right). The γ − γ dimer and α chain are indicated, as compared
with human synovial fluid, Fg, and Alb standards. Lanes represent human synovial fluid samples and resulting aggregates from different samples. (D) MSSA
aggregates stained for Alb, Fg, or secondary antibody alone (Control). All images are representative images of at least three samples.
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the Fg content of synovial fluid by ∼50%, depending
on the experiment.
To be able to determine the effect of altered Fg content
on bacterial aggregation, we set up a trypsin dispersal assay.
Specifically, we tested the ability of trypsin to digest surface
proteins and other proteinaceous components that facilitate
bacterial clustering in TSB and aggregation in pooled synovial
fluid [Figure 2B; n = 9 (TSB), 12–13 (SynF)]. MSSA that
typically exists in small clusters within TSB showed no
significant increase in CFU after trypsin treatment. In synovial
fluid, CFU were ∼1 log lower than the measured inoculum;
trypsin treatment resulted in an ∼1.5 log increase in CFU.
Thus, (1) synovial fluid aggregation reduced the number of
retrieved CFU by counting one large cluster as one colony, and
(2) trypsin treatment dispersed the aggregates to release the
bacteria from the aggregates. This trypsin dispersal resulted in
numbers of CFU consistent with those measured for the same
inoculum in TSB.
We asked if the Fg-depleted synovial fluid (depSynF)
supported MSSA aggregation (Figure 2C). No visible aggregation
was observed with depSynF, and the CFUs were approximately
equal to the initial inoculum (red dashed line). Addition of 6,
9, or 12 mg/ml of Fg caused a decrease in CFU, consistent
with increased aggregation. Notably, 9 and 12 mg/ml Fg caused
the largest decreases. In summary, we have demonstrated that

components of the bacterial synovial fluid aggregate. We also
confirmed the presence of Fg and Alb in bacterial aggregates
formed in pooled synovial fluid by immunostaining (Figure 1D).
Using antibodies to the two proteins, Fg or Alb staining was
clearly visible on the outside of the aggregates (in contrast
to the control staining with secondary antibody; confirmed
by microscopy of three aggregates). Collectively, these results
established the basic components of bacterial aggregates, guiding
our development of a viscous fluid for modeling bacterial
behavior in synovial fluid.

Fibrinogen Is Necessary for Bacterial
Aggregation in Human Synovial Fluid
We next sought to explore the involvement of Fg
in bacterial aggregation. To test its role, we ethanolprecipitated proteins from pooled human synovial fluid
to deplete Fg (among other proteins; n = 3) (Qiu et al.,
2003). By Western blotting (Figure 2A), the Fg content
of ethanol-precipitated human synovial fluid (depSynF)
was reduced compared with the parent pooled synovial
fluid; the precipitate (Ppt) had faint bands corresponding
to Fg. Approximate Fg concentrations were determined
by densitometric comparisons of band intensities for Fg
standards with experimental bands. Precipitation depleted

FIGURE 2 | Effects of fibrinogen (Fg) on aggregation. (A) Western blot showing Fg standards, amount of Fg detected in pooled human synovial fluid (equal amounts
added; percentage of synovial fluid in solution indicated), and amount remaining in synovial fluid after ethanol depletion of proteins including Fg (depSynF) and
amount in the Fg-enriched precipitate (ppt) (>3 blots with similar results). Densitometry of this Western blot is shown on the right using varying exposures. Fg
standards are plotted in the first graph and used to calculate Fg contained in the 5% samples. Areas associated with the experimental Fg samples were determined
and normalized to the 100-µg sample. (B) Effects of aggregation in pooled synovial fluid on colony-forming units (CFUs)/ml. Minus indicates no dispersion and
reflects counts obtained by dilution and counting. Plus indicates the counts after treatment of the cultures with trypsin to disperse aggregates. Values graphed are
means ± SD {*p ≤ 0.05; n = 9 [Trypticase Soy Broth (TSB)], 12–13 (Synovial fluid)}. (C) Re-addition of Fg to depSynF causes reacquisition of aggregation at 90 min,
as demonstrated by decreased CFU/ml. Red dashed line indicates the initial inoculum. Values graphed are means ± SD (*p ≤ 0.05; **p ≤ 0.01; n = 6 for each
condition; representative experiment of three with similar results for each).
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Fg is crucial for visible (macroscopic) S. aureus aggregation
in synovial fluid.

presence of 1.5 or 3.0 mg/ml HA or (b) 3.0 mg/ml HA in the
presence of 6 or 12 mg/ml Alb. We focused on the combination
that formed the intersection of the two groups, 12 mg/ml Alb and
3.0 mg/ml HA. Addition of Fg caused some MSSA aggregation
(n = 9; p < 0.001), as measured by decreased CFU. While
addition of Fg always increased bacterial aggregation, a clear
demarcation between the different Fg concentrations was not
consistent. Ultimately, based on similarities to synovial fluid, we
chose 12 mg/ml of Alb, 3 mg/ml HA, 10 mg/ml of Fg dissolved
in TSB for the final concentrations. This choice was based on (a)
12 mg/ml Fg was not suitable, as it caused acquisition of a gel-like
consistency to the bacteria-containing fluid (data not shown); (b)
there was no difference in bacterial aggregation between 6 and
9 mg/ml Fg; and (c) known range of Fg concentrations in synovial
fluid (Kushner and Somerville, 1971; Mateos et al., 2012; Bennike
et al., 2014). Statistical analyses are in table form (Supplementary
Material A1). We referred to this fluid as pSynF and asked if it
could model bacterial behavior in human native synovial fluid.

Combinations of Albumin, Fibrinogen,
and Hyaluronic Acid Can Recreate the
Aggregatory Phenotype
In keeping with the presence of Fg and Alb in MSSA/MRSA
aggregates, we investigated if both Fg and Alb contributed to the
aggregatory antimicrobial-tolerant bacterial phenotype. Because
HA contributes to the viscosity of synovial fluid (Park et al., 2014),
HA was also tested. A matrix of Alb, Fg, and HA concentrations
was created (Figure 3).
To measure aggregation, we looked at the dependence of
component concentration on total CFU, where decreases in
CFU were interpreted as increased aggregation. The addition of
HA visibly increased viscosity and aggregation for all Alb, Fg
concentrations/combinations. However, only 6 and 12 mg/ml
Alb contained HA concentrations that were statistically different
from 0 mg/ml HA (see statistical analysis in Supplementary
Material A1). Among the conditions containing 6 mg/ml Alb,
only 3.0 mg/ml HA (n = 36) resulted in lower CFU when
compared to 0 mg/ml HA (n = 35; p < 0.05). When the Alb
concentration was increased to 12 mg/ml, both 1.5 mg/ml (n = 34;
p < 0.001) and 3.0 mg/ml HA (n = 36; p < 0.0001) resulted in
greater aggregation, as manifested by lower CFU. Significantly
greater aggregation occurred with (a) 12 mg/ml Alb in the

Methicillin-Susceptible Staphylococcus
aureus in Pseudo Synovial Fluid
Aggregate and Display Amikacin
Tolerance
To determine if the proteins contained within pSynF were
able to reproduce the known characteristics of synovial fluid,
we first examined the morphology of a synovial fluid aggregate

FIGURE 3 | Protein addition assay. Methicillin-susceptible Staphylococcus aureus (MSSA) CFU/ml after growth in Trypticase Soy Broth (TSB) containing 0, 6, 12, or
18 mg/ml albumin (Alb). Increasing concentrations of hyaluronic acid (HA) and fibrinogen (Fg) are indicated in each panel. Decreased CFU/ml is a marker of
increased aggregation. Values graphed are means ± SD. Statistical analyses are included in the Supplementary Material A1 (n = 8–9/condition).
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FIGURE 4 | Effects of pseudo synovial fluid (pSynF) on methicillin-susceptible Staphylococcus aureus (MSSA). (A) Comparison of MSSA aggregates in human
synovial fluid (SynF) vs. pSynF using SEM. Magnification: scale bar = 15 µm. (B) Fibrinogen (Fg) (left) and albumin (Alb) (right) content of pSynF and pSynF
aggregates compared to aggregates formed in synovial fluid by Western blotting. (C) Graphs showing CFU/ml in Trypticase Soy Broth (TSB) and pSynF before
trypsin dispersion vs. CFU/ml after trypsin dispersion [(“after Tryp” in subsequent graphs) n = 12 for each condition]. (D) Effects of amikacin (AMK) on fluids
containing protein/proteoglycan concentrations found in pSynF. Controls are TSB alone and complete pSynF (n = 8–9 for each condition). All components were
dissolved in TSB. (E) Dose response of MSSA to AMK in TSB vs. synovial fluid (left; n = 9/condition) and of TSB vs. pSynF (right; n = 12/condition). (F) Viscosity of
pSynF compared to that of synovial fluid and H2 O using a ball velocity method (n = 10/condition). Values graphed are means ± SD. Viscosity is expressed as
centiPoise (cP). In panels (A–F), *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.

compared to that of pSynF (Figure 4A). By SEM, large floating
aggregates were formed in pooled synovial fluid and in pSynF.
These aggregates were partially covered with a biofilm layer that
obscured the finer details of the underlying aggregate; distinct
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fibers were only occasionally visible for either aggregate. By
Western blotting, pSynF aggregates showed the presence of Fg
and Alb (Figure 4B; independent replicates are shown on the
blot), as was observed in the synovial fluid aggregates. The α, β,
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and γ Fg monomers were present in pSynF. γ-γ dimers, which
were abundant in synovial fluid and synovial fluid aggregates,
were sparse in the pSynF aggregates.
We next wanted to test the effects of each of the components
apart and together on the antibiotic tolerance of bacteria. First,
we established that, like synovial fluid, aggregation resulted
in a decrease in CFU (Figure 4C; n = 12). Similarly, trypsin
treatment caused release of MSSA from the aggregates to reach
levels indistinguishable from those measured for the same
inoculum in TSB.
We then tested the effect of each of the different components
of pSynF when added to TSB on MSSA tolerance to AMK,
an aminoglycoside antibiotic important for severe infections
(Figure 4D; n = 8–9). In this experiment, all aggregates were
dispersed by trypsin before enumeration [CFU (after Tryp)]. In
TSB, 30 µg/ml of AMK eradicated MSSA (∼9 log decrease). In
12 mg/ml Alb + TSB, or 3 mg/ml HA +TSB, AMK tolerance
increased so that there was only an ∼5–5.5 log decrease. It is
notable that MSSA in Fg + TSB exhibited full sensitivity to AMK.
MSSA in either Alb + HA + TSB or Fg + Alb + TSB showed
intermediate tolerance (∼3 log decrease). MSSA exhibited the
greatest tolerance to AMK in Fg + HA + TSB and the complete
pSynF (HA + Fg + Alb + TSB) where 30 µg/ml AMK could only
decrease MSSA levels by ∼1.5 log.
We then compared MSSA antibiotic responsiveness in pooled
synovial fluid to that in pSynF (Figure 4E). In TSB, MSSA was
eradicated at all doses of AMK tested. In synovial fluid, 2–3 log
decreases were measured with increasing doses of AMK, although
no differences were significant presumably due to incomplete
dispersion of the fibrous aggregates resulting in a large variance.
Increasing AMK levels in pSynF caused dose-dependent 1.5–2.5
log decreases in MSSA CFU/ml (p < 0.001).
To complete these analyses, we measured the viscosity of
pSynF, an important property of the proteoglycan-rich synovial
fluid. While the viscosity of the pSynF (∼7.5 cP) was much
greater than that of water (∼1 cP), it was lower than the viscosity
of human synovial fluid, which was measured as ∼40 cP in our
system (Figure 4F). Collectively, these results indicate that pSynF
manifests similar bacterial aggregation and antibiotic tolerance
abilities to those seen in human synovial fluid.

expression levels of virulence factors under the control of agr,
PSMs alpha and beta, as well as the P3 promoter. The RLUs
of MRSA LAC USA300 strains that expressed luciferase under
control of psmα, psmβ, or P3 were determined by normalization
of the measured luminescence with the corresponding OD of the
growing cultures in TSB, serum, pooled synovial fluid, and pSynF
(Figure 5B; n = 6). P3 luc expression in TSB showed a rapid
and marked rise over time, whereas the expression in serum and
synovial fluid was only minimally detectable. However, P3 luc
expression in pSynF fell between that of synovial fluid and TSB,
despite the presence of aggregation. For both psmα and psmβ, luc
expression in TSB showed a marked steep rise over time, similar
to the expression patterns of P3 in TSB. As we had observed
previously, both serum and synovial fluid showed very low levels
of psmα and psmβ luc activity. Importantly, psmα and psmβ luc
expression patterns in pSynF were very similar to those measured
for serum and synovial fluid.

DISCUSSION
We have suggested that the phenotype of bacteria in the joint
directly impacts the ability of antimicrobials to combat PJI,
a devastating complication of joint replacements. In previous
work, we showed that synovial fluid, the lubricious fluid within
the joint space, causes aggregation of many bacterial species,
including MSSA and MRSA. Furthermore, we established that
proteinase K and tissue plasminogen activator (tPA), presumably
through activation of the serine protease plasmin, can inhibit
aggregate formation, disperse the floating MSSA or MRSA
aggregates formed in synovial fluid, and restore antibiotic
sensitivity (Dastgheyb et al., 2015a,b; Gilbertie et al., 2019).
These observations were given further rigor by examining MRSA
USA300 strains from the Nebraska transposon bank, with which
we previously showed (Dastgheyb et al., 2015b) that macroscopic
aggregation could be abrogated in strains that had insertions
in fibronectin-binding proteins A and B (FnbA and FnbB),
the fibrinogen-binding Clumping factor A and B (ClfA and
ClfB), and RsbU and TRAP, which are regulatory proteins
(Dastgheyb et al., 2015c). Others have suggested a role for Fg
and Fn in this aggregation (Walker et al., 2013; Pestrak et al.,
2020). In this study, we characterized the protein content of
these aggregates and set about testing which components of
these aggregates were critical for this bacterial association. MSSA
aggregation was dependent on increased viscosity, Alb, and Fg.
We used both MSSA and MRSA strains in this work as their
aggregation behavior is similar and importantly, so that our
measurements of virulence factor production could be compared
with our previously published work in synovial fluid (Dastgheyb
et al., 2015c). Ultimately, we formulated a pSynF that could be
used to study this aggregation and its effects on bacterial virulence
factor production.
In the infected joint, macroscopic mucinous aggregates
are routinely present and have morphological similarities to
the aggregates formed in vitro in synovial fluid. While these
aggregates show many normal components of a biofilm, based
on our earlier work, the degradation of PIA or extracellular

Virulence Factor Expression in Pseudo
Synovial Fluid and Synovial Fluid
Previously, we showed that both MSSA and MRSA aggregates,
i.e., floating biofilms, formed in synovial fluid were covered with
a polysaccharide intercellular adhesin (PIA) matrix (Dastgheyb
et al., 2015a,b,c; Gilbertie et al., 2019). We thus examined WGA
staining of the biofilm matrix (Figure 5A). Staining was sparse
in bacteria grown in TSB. WGA staining was more intense in
both synovial fluid (pooled) and pSynF and similar in intensity,
suggesting similar levels of PIA production.
S. aureus virulence factor expression, which is under the
control of the agr operon, is also highly influenced by
the microenvironment. We have previously shown that virulence
factor production in S. aureus is downregulated in synovial
fluid (Dastgheyb et al., 2015c). We therefore sought to measure
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FIGURE 5 | Biofilm and virulence factor expression as a function of medium. (A) Comparison of wheat germ agglutinen staining of polysaccharide intercellular
adhesin (PIA) in methicillin-susceptible Staphylococcus aureus (MSSA) grown in Trypticase Soy Broth (TSB), pooled synovial fluid, or pseudo synovial fluid (pSynF).
(B) Expression of luciferase under control of P3, psmα, or psmβ promoters using MRSA LAC300 strains in TSB, serum, pooled synovial fluid, and pSynF. Each line
represents the average of three independent experiments performed in duplicate. Values graphed are means ± SD. Statistics are available in Supplementary
Material A2.

DNA is insufficient to disrupt the aggregates – a proteinase
is required (Dastgheyb et al., 2015b). We thus set out to
examine the components of synovial fluid aggregates. Synovial
fluid is a filtrate of human serum and is enriched with
proteoglycans produced by synoviocytes and chondrocytes. We

Frontiers in Microbiology | www.frontiersin.org

used both individual and pooled samples of human synovial fluid,
with similar results on aggregation, protein composition, and
antibiotic tolerance. Unlike synovial fluid, serum aggregates tend
to be small except in end-stage sepsis (Iskander et al., 2013).
In vitro, aggregation in serum, albeit microscopic, does occur
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synovial fluid, although individual and cross-linked chains of
Fg were not always equivalent in the pSynF vs. synovial fluid
aggregates, perhaps pointing to the absence of the Fg crosslinking cascade in pSynF. When aggregates were viewed without
magnification, the pSynF aggregates were uniformly smaller than
those formed in synovial fluid and in clinical cases where we
have observed retrieval of more mucinous aggregates. It is of
course probable that other proteins will have roles in subtly
modifying the stability, antibiotic sensitivity, and morphology
of the aggregates. We would suggest either the localization
of additional proteoglycans found in synovial fluid or greater
production of PIA, as well as perhaps additional proteins,
that modifies the density of the aggregate. Possibilities would
include collagen that binds to the same MSCRAMMs previously
identified and Fn, a protein that decorates most extracellular
matrices; all are present in synovial fluid. Interestingly, the Fg
and Alb content of synovial fluid increases in the osteoarthritic
joint (Mateos et al., 2012; Bennike et al., 2014). We similarly
expect an increase in the infected joint, making them more
available for bacterial aggregation. Nevertheless, both human
synovial fluid and pSynF conferred marked antibiotic tolerance
to MSSA aggregates, with similar decreases when compared to
the untreated control.
While clinically relevant joint-lubricating fluids (Adams et al.,
1995; Neustadt et al., 2005; Mathies, 2006; Petterson and
Plancher, 2019), as well as those for the study of rheology (Radin
et al., 1971; Takadama and Mizuno, 2006; Bortel et al., 2015),
have been formulated, our goal was to study bacterial responses to
synovial fluid proteins. Interestingly, the viscosity of pSynF, while
∼7× that of water, was still lower than that which we measured
for native synovial fluid, even though the concentrations of HA
tested were informed by known amounts of HA in synovial
fluid. A number of proteoglycans produced in the joint capsule
contribute to this viscosity, including the MW of the HA itself
and an important role played by the lubricin macromolecule (Jay
et al., 2007). Importantly, despite the difference in viscosity, both
pSynF and synovial fluid caused marked antibiotic tolerance. An
important role for viscosity/polarity of the medium was indicated
by the requirement for HA to obtain the full antibiotic tolerance
associated with Fg or Fg + Alb. The importance, however, of
understanding the underpinnings of this antibiotic tolerance
remains focused on restoring antibiotic susceptibility, especially
as the mechanism is likely to be the same poorly defined bacterial
metabolism and protein expression changes that characterize
the biofilm phenotype. By defining the importance of the three
components within pSynF, we also define targets for therapeutic
interventions. One such possibility already exists with our reports
of tPA dispersal (and restoration of antibiotic susceptibility) to
the MSSA aggregates.
Further emphasizing the similarity of these aggregates to
biofilms, both synovial fluid and pSynF formed PIA-encased
aggregates that were similar in morphology and apparent
intensity of WGA staining. Furthermore, expression levels of
PSM-α and -β reporter plasmids suggested that Fg, Alb, and
HA are key mediators of bacterial behavior in synovial fluid,
especially as similar magnitudes and kinetics of expression
were noted in serum, synovial fluid, and pSynF. However,

(Walker et al., 2013; Dastgheyb et al., 2015a), but it is worth
noting that laboratory serum has had Fg precipitated or crosslinking inhibited during the process of collection and isolation.
Taken together, we thought that Fg and perhaps proteoglycans,
specifically HA, would be necessary for recapitulating the
aggregatory phenotype. In fact, others have shown that Fg
and Fn can cause bacterial aggregation when added to ideal
media (Pestrak et al., 2020), which is consistent with our earlier
experiments with aggregate dispersion.
Using aggregates from three independent human synovial
fluid samples, the aggregate protein content and concentrations
were determined to be similar to those of the parent synovial fluid
by SDS-PAGE. Furthermore, the apparent protein distribution
mirrored the pattern of human serum (within the limits of
Coomassie blue staining) (Lyngbye and Krøll, 1971). Based on
known proteins in serum and synovial fluid and their relative
abundance (Ritter et al., 2013; Bennike et al., 2014), we identified
Alb and Fg as major components of the aggregate, with a
number of minor components that we did not identify. While our
previous work and that of others using tPA suggested a critical
role for Fg (Dastgheyb et al., 2015a,b; Gilbertie et al., 2019; Pestrak
et al., 2020), only through Fg complementation could its role
be established. Thus, we depleted pooled synovial fluid of Fg
by ethanol precipitation of proteins. Nevertheless, the ethanol
precipitation, while enriching the precipitate for Fg, precipitated
other proteins that could also play a role in the bacterial response
to synovial fluid, e.g., aggregation. However, addition of Fg
back to the ethanol-precipitated synovial fluid restored visible
aggregation and supported its proposed role, in keeping with
our published work and work by others (Walker et al., 2013;
Dastgheyb et al., 2015a,b,c; Pestrak et al., 2020). Bacterial binding
to these proteins would use the MSCRAMMs that, through
use of MRSA USA300 strains from the Nebraska transposon
bank, we previously showed moderated macroscopic aggregation
(Dastgheyb et al., 2015b). Specifically, aggregation could be
abrogated in strains that had insertion mutations in FnbA and
FnbB, the ClfA and ClfB, prominent MSCRAMMs, and RsbU and
TRAP, which are regulatory proteins (Dastgheyb et al., 2015c).
Interestingly, Alb and HA were also important for aggregation,
as demonstrated in the combinatorial addition experiments.
Within the range of 1.5–3.0 mg/ml HA, 6–12 mg/ml Alb, and
6–12 mg/ml Fg, MSSA and MRSA aggregated, as evidenced by
decreased CFU. Furthermore, if only one of the components
was present, the ability to reproduce the characteristic antibiotic
tolerance was attenuated. Interestingly, antibiotic tolerance
measured in HA + Fg + TSB was similar to that in pSynF,
despite the dependence on Alb that aggregation was shown
to have. It is interesting that the Fg concentration showed
an upper limit as the 12 mg/ml Fg concentrations started to
become more gel-like (rather than distinct aggregates) in the
presence of MSSA. Importantly, we chose the concentrations
of the different components based on statistical tests using
aggregation, antibiotic tolerance, and ultimately literature values
for human synovial fluid (which fell within the ranges we had
determined) (Mateos et al., 2012; Bennike et al., 2014).
The proteins sequestered within the MSSA aggregates formed
in pSynF approximated the protein composition of that in human
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it is not clear if the lower viscosity, or perhaps the use of TSB as
the reconstituting medium, led to a difference in P3 expression
by MRSA USA300. Finally, we used P3 expression as a readout
of Agr regulation. As Agr regulates quorum sensing, as well as
the expression of a subset of virulence factors (Dastgheyb and
Otto, 2015), it becomes important to elucidate the additional
components that suppress P3 expression and, by implication, Agr
activity in human physiological fluid. Finally, we would suggest
that the overall reproduction of aggregation, biofilm slime,
antibiotic resistance, and PSM expression suggests that these
three components are critical mediators of bacterial phenotype
and in the process furnish an important tool to determine
bacterial/biomaterial interactions in a system that more faithfully
reproduces the in vivo environment.
In summary, we have identified Fg, Alb, and HA as critical
components responsible for bacterial aggregation in synovial
fluid and that together, as presented in pSynF, these proteins
interact with MSSA and MRSA to recapitulate the majority of
the properties of MSSA or MRSA in synovial fluid aggregates.
Importantly, as we have previously shown, both serum and
synovial fluid cause marked decreases in virulence factor
expression, in contrast to many studies suggesting an apparent
increase in Agr-controlled genes associated with infections
(Le and Otto, 2015). Our studies emphasize the importance of
using physiological and model physiological fluids such as
this pSynF in studying bacteria–biomaterial interactions. This
formulated pSynF can, in fact, be used as a reasonable alternative
for studying in vitro models of PJI and septic arthritis, as well
as providing a more realistic medium for the development of
antimicrobial strategies/materials for implants.
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